Ankylosing spondylitis

Akeso Scores Two Wins in Phase 3 Trials, Tees Up Regulatory Submissions in China

2 weeks ago talkbio0Tagged Akeso, Ankylosing spondylitis, Autoimmune Diseases, China, Clinical Trials, Dermatitis, Atopic, Gumokimab, Manfidokimab, regulatory submission

Akeso; Phase 3 trials; gumokimab; manfidokimab; ankylosing spondylitis; atopic dermatitis; regulatory submission; China; autoimmune diseases; clinical trial results

UCB Expands Bimzelx Indications with Three New FDA Approvals for Chronic Inflammatory Diseases

12 months ago talkbio0Tagged Ankylosing spondylitis, approvals, Arthritis, Psoriatic, Bimzelx, IL17A protein, human, IL17F gene, Inhibitor, non-radiographic axial, Spondylarthritis, UCB, United States Food and Drug Administration

Bimzelx, UCB, FDA approvals, psoriatic arthritis, non-radiographic axial spondyloarthritis, ankylosing spondylitis, IL-17A, IL-17F inhibitor

FDA Approves Bimzelx for Expanded Indications: Psoriatic Arthritis, Non-Radiographic Axial Spondyloarthritis, and Ankylosing Spondylitis

12 months ago talkbio0Tagged Ankylosing spondylitis, Approved, Arthritis, Psoriatic, Bimzelx, IL-17F inhibitor, IL17A protein, human, non-radiographic axial, Spondylarthritis, United States Food and Drug Administration

Bimzelx, FDA approval, psoriatic arthritis, non-radiographic axial spondyloarthritis, ankylosing spondylitis, IL-17A and IL-17F inhibitor